Gilead Sciences
GILD
GILD
1,593 hedge funds and large institutions have $59B invested in Gilead Sciences in 2022 Q1 according to their latest regulatory filings, with 144 funds opening new positions, 695 increasing their positions, 560 reducing their positions, and 208 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,593
Holders Change
-82
Holders Change %
-4.9%
% of All Funds
25.21%
Holding in Top 10
24
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+4.35%
% of All Funds
0.38%
New
144
Increased
695
Reduced
560
Closed
208
Calls
$1.38B
Puts
$1.22B
Net Calls
+$152M
Net Calls Change
+$382M
Top Buyers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$818M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$405M |
| 3 |
Renaissance Technologies
New York
|
+$381M |
| 4 |
D.E. Shaw & Co
New York
|
+$265M |
| 5 |
Millennium Management
New York
|
+$216M |
Top Sellers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$3.04B |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$1.81B |
| 3 |
Amundi
Paris,
France
|
-$249M |
| 4 |
Barclays
London,
United Kingdom
|
-$145M |
| 5 |
Morgan Stanley
New York
|
-$126M |
